Discover 1,688 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Boston MA, Philadelphia PA, Baltimore MD, Nashville TN,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: Male
Age: 2 - 65
Code: NCT06430385
Phase 1, Phase 2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Burlington MA, Norfolk MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Boston MA, Lebanon NH, Morristown NJ,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Sydney, Boston MA, Providence RI, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase 3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Solid Tumor, Advanced Solid Tumor,
Location: Boston MA, New York NY, Fairfax VA, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06561685
Phase 1, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Stony Brook NY, York PA, Washington DC DC,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase 1, Recruiting
Interstitial Lung Disease in Early Rheumatoid Arthritis
for
Rheumatoid Arthritis, Interstitial Lung Disease
Location: Denver CO
Sponsor: National Jewish Health
Sex: All
Age: 18 - 70+
Code: NCT03977415
Recruiting
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Boston MA, Philadelphia PA, Fairfax VA, Jacksonville FL,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06720987
Phase 1, Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Location: New York NY, Philadelphia PA, Hershey PA, Danville PA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05519475
Phase 2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects
for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: Boston MA, New Hyde Park NY, New York NY,
Sponsor: Jubilant DraxImage Inc.
Sex: All
Age: 1+
Code: NCT03561259
Phase 2, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase 3, Recruiting
Specimen Banking From Patients With Lung Cancer
for
Lung Neoplasms
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT01585675
Recruiting
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
for
Survivors of Childhood Cancer, Bladder Dysfunction